Market Trends of Bone Grafts And Substitutes Industry
The Dental Segment is Expected to Register Significant Growth in the Market Studied Over the Forecast Period
The dental segment is expected to witness significant growth in the market owing to factors such as the rising incidence of dental diseases among the population and increasing dental visits. Also, advancements in dental graft systems coupled with a rise in strategic activities may augment the market growth over the forecast period.
The increasing burden of dental diseases such as dental caries and periodontal diseases among the population is likely to boost the demand for dental surgeries and increase the number of dental visits. For instance, according to the 2022-2023 Annual Report of the NHS Dental Statistics for England, 32.5 million dental courses of treatment were delivered from 2022 to 2023 in the country, an increase of 23.2% compared to the previous year. Thus, an increase in dental procedures and visits may increase the chances of adopting dental grafts and substitutes for different dental diseases, thereby promoting market growth over the forecast period.
Furthermore, the rising adoption of various business strategies such as acquisition, collaboration, and product launches by the companies is also contributing to the growth of the market. For instance, in April 2023, ZimVie Inc. unveiled two new additions to its biomaterials portfolio. The first, the RegenerOss CC Allograft Particulate, is a natural blend of cortical and cancellous bone particles designed to fill bony voids in various dental applications. The second, the RegenerOss Bone Graft Plug, offers a user-friendly solution for filling extraction sockets and addressing periodontal defects. Both products are accessible throughout North America. Hence, owing to such advanced product launches, the dental segment is expected to witness notable growth over the forecast period.
Thus, due to the increase in dental diseases and the rise in strategic activities by the key players, the dental segment is expected to witness significant growth over the forecast period.
North America is Expected to Record Significant Market Share Over the Forecast Period
North America is expected to record significant market growth in the bone grafts and substitutes market over the forecast period owing to factors such as the increasing prevalence of joint disorders and dental diseases, growing dental visits, rising technological advancement, and the presence of a well-established healthcare infrastructure.
The burden of dental diseases and joint-related disorders such as osteoarthritis, arthritis, and rheumatoid arthritis among the population is increasing rapidly, which is likely to increase the demand for bone grafting procedures for removing small bones from grinding against each other to provide relief and remove the inflamed bone from the area, thereby propelling the market growth.
For instance, according to Statistics Canada’s November 2023 update, 6.2 million adult Canadians aged 65 years and over were diagnosed with arthritis in 2022. The prevalence of arthritis increases with age and is higher among females. Similarly, according to the February 2024 update by CIHI, the second most common inpatient surgery in Canada in 2022–2023 was knee replacement (2.6 days) and hip replacement (6.1 days). Consequently, rising bone-related ailments, extended hospital stays, and associated diseases are projected to drive growth in the bone grafts and substitutes market during the forecast period.
Moreover, the rising focus on research and development activities by companies, regulatory approvals, adoption of bone grafts by patients, and increasing product launches are also contributing to the market's growth.
For instance, in May 2024, OssDsign AB (publ.) reported that 5,000 patients benefited from the cutting-edge nanosynthetic bone graft OssDsign Catalyst. In September 2023, graft was used to treat 2,000 patients, up from 1,000 in May 2023. OssDsign Catalyst, a nanosynthetic bone graft, promotes the development of healthy bone tissue during spinal fusion surgeries. This graft features a unique nanocrystalline structure, which the body gradually resorbs, subsequently replacing it with new, healthy bone tissues. Thus, the abovementioned strategic activities by the key players in North America are expected to augment the market growth.
Thus, considering the rising incidence of dental diseases and joint disorders and increasing product launches in the region, the bone grafts and substitutes market is expected to grow rapidly over the forecast period.
